Objective. The aim of this study was to validate the modified 2010 ACR preliminary criteria for FM in a Spanish population.
Introduction
FM has become a worrisome health condition in our modern society. This condition was first referred to as fibrositis and was mainly centred on diffuse pain [1] . A few years later, Yunus et al. [2] called it fibromyalgia and proposed a set of criteria for its diagnosis, including tender points and the presence of different symptoms. In 1990 the ACR reported the first criteria to differentiate FM from other chronic widespread pain syndromes [3] . Twenty years later, new, presumably improved ACR preliminary FM criteria have been released [4] .
The 1990 ACR criteria (hereinafter referred to as 1990c) required widespread pain for at least 3 months and the presence of 11 of 18 tender points [3] . As time passed, objections to the 1990c developed, on the grounds that the presence of different tender points cannot be an objective assessment of whole body pain [5] . Furthermore, digital palpation instead of algometry is the most widely used method among examiners [6] . Without an objective instrument, the application of an equal pressure of 4 kg is therefore doubtful [5, 6] . Finally, FM is defined as a complex multidimensional pain disorder [4, 7] with the inclusion of equally presumably important non-pain symptoms, such as fatigue, stiffness, depression and cognitive problems, among other complaints [7, 8] . The range of these symptoms is therefore another important weakness of the 1990c [4, 5] .
In 2010 the ACR released new diagnostic criteria that simplified clinical diagnosis by avoiding the requirement of examination of tender points [4] . With the new 2010 ACR criteria, FM has turned into a systemic symptom-based condition rather than the previous peripheral pain-defined condition [5] . Because most of the 2010 ACR items were obtained by self-administration, the criteria were modified in 2011 to allow complete self-administration [9] . These new criteria, which we shall call the m-2010c, eliminated the physicians' subjective assessments, thus making it a self-administered questionnaire suitable for epidemiological studies [9] .
The m-2010c represent an alternative FM assessment method. However, it is not known whether the m-2010c are a valid diagnostic tool in different populations, and further investigations in different countries have been requested. To date, the 2010 ACR criteria have been validated in English- [4] , Japanese- [10] , French- [11] and Iranian- [12] speaking populations, whereas the m-2010c have been validated in English- [9] and Japanese- [13] speaking populations. To the best of our knowledge, no previous research has studied the validity of the m-2010c in Spain. Therefore we aimed to validate the m-2010c for FM in a representative population from southern Spain.
Patients and methods

Participants
FM patients were recruited from various FM associations via e-mail, letter or telephone. We also asked those FM patients interested in participating to recruit a healthy individual (control) of similar age, socio-demographic characteristics and demographic area in order to carry out appropriate comparisons between groups. We additionally contacted control participants via e-mail and Internet advertisements. All interested participants (n = 960) signed a written informed consent after receiving detailed information about the aims and study procedures. The study assessments were carried out between November 2011 and January 2013. The inclusion criteria for FM participants were (i) previous diagnosis of FM by a rheumatologist (patients were asked to provide their medical records to confirm their previous diagnosis) and (ii) no acute or terminal illness (such as cancer, stroke, recent cardiopathy, severe coronary disease, schizophrenia or any other disabling injury) or severe dementia [mini mental state examination (MMSE) < 10] [14] . The inclusion criteria for control participants were (i) no previous diagnosis of FM by a rheumatologist and (ii) no acute or terminal illness or severe dementia (MMSE < 10). A total of 39 participants were excluded from the study. One had an MMSE score <10 and the other 38 participants suffered from pain, although they had not previously visited a rheumatologist for a FM diagnosis. A total of 921 participants from southern Spain were enrolled in the study, which was reviewed and approved by the Ethics Committee of the Hospital Virgen de las Nieves, Granada, Spain.
Outcome measures
We assessed 18 tender points according to the 1990c [3] using a standard pressure algometer (FPK 20; Wagner Instruments, Greenwich, CT, USA). The mean of two measurements at each tender point was used for the analysis. A tender point scored as positive when the patient noted pain at a pressure 44 kg/cm 2 . The total count of positive tender points (tender points count) was recorded for each participant. An algometer score was calculated as the sum of the minimum pain-pressure values obtained for each tender point.
The questionnaire for the m-2010c [9] is composed of two scales. The widespread pain questionnaire asked participants to grade whether (or not) they had pain or tenderness over the previous week in 19 body areas (shoulder girdle, hip, jaw, upper arm, upper leg, lower arm and lower leg, on the right and the left side of the body, separately, and additionally neck, chest, abdomen, upper back and lower back). Each item was scored as 0 or 1. The minimum total score of the widespread pain index (WPI) was 0 and the maximum total score was 19. The symptom scale questionnaire asked participants to indicate the severity of fatigue, trouble thinking or remembering and waking up tired (unrefreshed) over the previous week. The possible values were 0 (no problem), 1 (slight or mild problems, generally mild or intermittent), 2 (moderate, considerable problems, often present and/or at a moderate level) and 3 (severe, continuous, life-disturbing problems). Patients were also asked to answer whether (or not) they had had pain or cramps in the lower abdomen, depression or headache during the previous 6 months. The minimum total score of symptom severity (SS) was 0 and the maximum total score was 12. The WPI and SS were subsequently summed into a 031 index originally called the fibromyalgianess scale [9] and subsequently termed the polysymptomatic distress (PSD) scale [7] . The original 2010 ACR criteria study and the corresponding questionnaire have been previously translated to Spanish (see http://www.institutferran. org/documentos/WPI+SS-PACIENTES.pdf and http:// www.institutferran.org/documentos/2010_ACR_FM_ TRAD_FINAL.pdf). We used this questionnaire, with the exception that we adapted the second part of the SS to the m-2010c: the physicians' estimation of the SS score was eliminated and replaced with three dichotomous yes/ no responses regarding the presence of pain or cramps in the lower abdomen, depression or headache during the previous 6 months, as explained above. The questionnaire was self-administered and patients obtained directions from the researchers when they did not understand the questionnaire instructions.
The revised Fibromyalgia Impact Questionnaire (FIQR) is a self-administered questionnaire comprising 21 individual questions with a rating scale of 010. The questions compose three different domains: function, overall impact and symptoms score (range 030, 020 and 050, respectively) [15, 16] . The FIQR total score ranges from 0 to 100, with a higher score indicating a greater impact of the condition on the person's life.
The 36-item Short Form Health Survey (SF-36) is a generic instrument for assessing health-related quality of life [17, 18] . Its 36 items are grouped into eight dimensions: physical functioning, physical role, body pain, general health, vitality, social functioning, emotional role and mental health. The scores range from 0 to 100 for every dimension, and higher scores indicate better health.
The Multidimensional Fatigue Inventory (MFI) measures fatigue severity. It comprises five subscales: general fatigue, physical fatigue, mental fatigue, reduced activity and reduced motivation [19, 20] . Each subscale includes four items on a 5-point Likert scale. Scores on each subscale range from 4 to 20, with higher scores indicating greater fatigue. In the present study we only focused on general fatigue, which includes general statements about fatigue and decreased functioning.
The Beck Depression Inventory II (BDI-II) was used to assess depression severity [21, 22] . It contains 21 items and the score ranges from 0 to 63, with a higher score indicating greater depression.
The MMSE was used to assess cognitive capacity and the severity of dementia for the exclusion criteria [14, 23] . Five areas of cognitive functioning were assessed: orientation, immediate memory, attention/concentration, delayed recall and language. The score ranges from 0 to 30, with a lower score indicating a greater state of dementia.
Statistical analysis
Differences in socio-demographic variables between groups were calculated with analysis of variance (ANOVA) or the chi-square test when appropriate. Differences in clinical variables were calculated with analysis of covariance (ANCOVA), adjusting for all significant socio-demographic variables. The relationship between the tender points count, the new criteria scales and the other important study variables was studied using Pearson's correlation coefficient (r p ). Cronbach's a was used to measure the internal consistency for the m2010c. The sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), positive likelihood ratio (PLR), negative likelihood ratio (NLR) and accuracy for the 1990c, the m-2010c and the combination of both criteria were calculated. The kappa and delta indexes [24] were additionally used to measure the agreement between the gold standard (clinical/rheumatologist diagnosis) and FM criteria. New cut-off points that could represent better test characteristics than those presented in the original m-2010c were studied by means of receiving operator characteristic (ROC) analysis. Significance was set at P < 0.05. The Statistical Package for Social Sciences, version 20.0 (SPSS Statistics for Windows, IBM, Armonk, NY, USA) was used.
Results
A total of four participants did not assist to the tender points assessment and 44 participants did not fill out the questionnaires. The final study sample comprised 873 participants. According to the clinical (rheumatologist) diagnosis, 579 (550 women) participants became part of the FM group, whereas 294 (240 women) participants were included in the control group.
The socio-demographic characteristics of the study groups are shown in Table 1 . Age, sex, educational status and occupational status were statistically different between the FM and control groups (all P < 0.001). The clinical characteristics of the study groups are shown in Table 2 . A significant difference in all the clinical variables between the FM and control groups was observed (all P < 0.001), except in the MMSE (P > 0.05).
To further characterize the relationship between the tender points count, the new criteria scales and the study variables, Pearson correlations are shown in Table 3 . The correlations between the tender points count and the WPI, SS and PSD were 0.69, 0.65 and 0.71, respectively (all P < 0.001). The scales of the new criteria (WPI, SS and PSD) showed greater correlations with all the study variables than the tender points count.
We applied the 1990c and the m-2010c to participants enrolled in the study. By clinical diagnosis at entry, 63.6% of the total participants were diagnosed with FM. Using 1990c, the percentage of total participants with FM was 58.4, whereas with m-2010c it was 61.0 (Table 4) . Among participants completing the FM clinical diagnosis, 84.1% satisfied the 1990c and 88.3% satisfied the m-2010c. Among control participants, 2.4% were diagnosed with FM according to the 1990c and 8.2% according to the m-2010c.
The all-item internal consistency of the m-2010c showed a Cronbach's a of 0.93. The sensitivity, specificity, PPV, NPV, PLR, NLR and accuracy of the 1990c and m-2010c were calculated using the clinical diagnosis as the gold standard ( Table 5 ). The m-2010c showed a greater sensitivity but lower specificity than the 1990c (88.3 vs 84.1 and 91.8 vs 97.6, respectively). Both criteria showed the same overall accuracy, with a value of 0.89. We further studied the combination of both the 1990c and m-2010c. When patients had to satisfy both criteria to be diagnosed (1990c + m-2010c), the sensitivity was low (75.6), despite the fact that the specificity was almost perfect (99.7). When patients had to satisfy one of the criteria to be diagnosed (1990c or m-2010c), the sensitivity and specificity were both very high (96.7 and 89.8, respectively) and the accuracy, with a value of 0.94, was higher than all the previous options. The kappa and delta values for the 1990c and m-2010c were similar and overall they were good (>0.75). The 1990c + m-2010c combination showed the lowest kappa value, whereas the 1990c or www.rheumatology.oxfordjournals.org m-2010c showed the best kappa and delta values from all options (see Table 5 ).
We analysed different cut-off points for the WPI and the SS score. We did not observed new cut-off points with better characteristics with maximal area under the curve than those provided in the original m-2010c (WPI 5 7 and SS 5 5 or WPI 36 and SS 5 9) (data not shown). Comparisons between the FM group and the control [9] All participants (n = 7233) 10.1 -25.4 FM (n = 729) 100 -60.0 Control (n = 6504) 0 -21.6 Japanese modified 2010 ACR criteria [13] All participants (n = 693) -66.7 44.0 FM (n = 462) -100 64.0 Control (n = 231) -0 4.0 Original 2010 ACR criteria [4] All participants (n = 514) 50.2 -38.1 FM (n = 258) 100 -74.5 Control (n = 256) 0 -2.0 Japanese 2010 ACR criteria [10] All participants (n = 137) -68.6 59.1 FM (n = 94) -100 82.0 Control (n = 43) -0 9.0 Iranian 2010 ACR criteria [12] All participants (n = 278) 60.4 47.8 38.4 FM (n = 168) 100 71.4 58.9 Control (n = 110) 0 11.7 7.2
The gold standard selected in each validation study is highlighted in bold. www.rheumatology.oxfordjournals.org group were carried out using ROC analyses for the PSD. Several cut-off scores for the PSD, together with the sensitivity, specificity, PPV, NPV, PLR, NLR and accuracy are shown in Table 6 . The best cut-off scores for the PSD were 12 and 13, with a sensitivity of 95.7 and 93.6, respectively, a specificity of 84.7 and 87.4, respectively, and an accuracy of 0.92. A graphical representation of the results from the ROC analyses is presented in supplementary Fig. S1 , available at Rheumatology Online. All analyses were repeated with age-matched groups (3565 years) and sex-separated groups, and the results remained unchanged.
Discussion
The present study showed acceptable validity of the m2010c as a FM diagnostic tool. When clinical diagnosis was applied as the gold standard, the m-2010c showed greater sensitivity but lower specificity than the 1990c. The cut-off score (WPI 5 7 and SS 5 5 or WPI 36 and SS 5 9) published in the original version perfectly fitted our sample and no different cut-off scores showed a substantial improvement. The PSD best cut-off points were 12 and 13, similar to the original version [4, 9] . The combination of both 1990c and m-2010c showed the best test characteristics for the diagnosis of FM.
Age, sex, educational status and occupational status differed between the FM and control groups. Lower levels of education have been associated with an increased prevalence of pain [25] and a higher prevalence rate of FM [26] . Furthermore, FM directly impacts work ability, which implies an indirect economic repercussion. Lower incomes have also been related to a higher prevalence of FM [2527] . As expected, clinical variables were statistically different between the FM and control groups. Furthermore, the differences observed in tender points count, SS, WPI and PSD between the FM and control groups speaks favourably about the internal consistency of both the 1990c and the m-2010c.
Higher correlations were observed between the m2010c and various study variables (FIQR, SF-36, MFI and BDI-II) than those obtained for the 1990c and the aforementioned study variables. In line with these results, it has been previously stated that the m-2010c and FIQR can be somewhat compared [9] . We showed a low correlation (r p = 0.24) between the tender points count and FIQR, which indicates that the tender points count by itself may be a poor indicator of FM impact. These results have been shown previously with the FIQ [28, 29] . However, the correlation between the PSD and FIQR was stronger (r p = 0.65) than that observed between the tender points count and the FIQR. This fact, together with the moderate to high correlation with general fatigue and depression (two other highly important FM symptoms [8] ) emphasizes the concept of FM as a multisymptom dimensional condition. There is no gold standard for the diagnosis of FM, which represents a problem when assessing the validity of new criteria. In the absence of this gold standard, an expert consensus was first adopted by Wolfe et al. [3] in the 1990c validation study. Subsequently this approach was used in both the 2010 original version and m-2010c [4, 9] . Following this approach, we adopted clinical diagnosis as the gold standard to study the validity of the m-2010c, as previously done in a recent FM criteria validation study in an Iranian population [12] .
From the total number of FM participants recruited and diagnosed by rheumatologists, the m-2010c positively identified 88.3%, whereas the 1990 criteria positively identified 84.1%. However, the m-2010c incorrectly classified a higher percentage of control participants as having FM than the 1990 criteria (8.2 vs 2.4%). Compared with previous validation studies of the 2010 ACR criteria [4, 10, 12] and m-2010c [9, 13] , our results were most accurate when positively identifying FM patients, whereas the incorrect classification of control participants was similar to that presented in previous studies. We further studied the possibility of using both the 1990c and the m-2010c together. Two options were available: (i) participants had to satisfy both criteria to be diagnosed as having FM or (ii) participants had to meet one of two criteria. Although the approach explained in the first option is excellent to reject those without FM (specificity = 99.7), the ability to detect patients with FM was fairly low (sensitivity = 75.6) compared with the 1990c and m-2010c by themselves, which is not acceptable. However, the second option revealed some surprising results, with a sensitivity of 96.7, specificity of 89.9 and accuracy similar for all options. The kappa and delta values for both the 1990c and m-2010c indicated good agreement between these criteria and the clinical diagnosis. Following the same pattern as above, the 1990c or m-2010c combination showed the best agreement. This combination of criteria had not previously been reported, but it seems that when the combination of the two criteria is available, satisfying one of two criteria shows the best overall characteristics to meet the diagnosis of FM. As recently shown, FM patients might not necessarily fulfil the tender points criteria to be diagnosed [30] , which agrees with our findings. Furthermore, this criteria combination might help to identify more homogeneous subgroups of patients (e.g. those fulfilling only 1990c, m-2010c, or both criteria). In practice, this would imply retaining clinical and objective review of tender points examination, which would not be ideal in relation to certain types of study such as surveys and large epidemiological studies. However, this would be reasonable (and more accurate overall according to the results of the present study) in the context of clinical practice. Perhaps the m-2010c might be used a priori, due to its simplicity, quickness and self-administration; and for those patients not fulfilling these criteria, the 1990c could provide additional information in order to reach a final diagnosis.
The understanding of FM as a multidimensional disorder raises the importance of the PSD as an FM scale [7] . FM patients are a heterogeneous group and thus their symptomatology may vary between different populations, regions and/or countries [7] . Therefore we studied the possibility of new cut-off points that were able to improve the diagnostic accuracy of the m-2010c. We did not observe any improvement with different cut-off points than those proposed by Wolfe et al. [4] in the original version. The PSD has been identified as an important index that might allow FM to be mapped on a dimensional or continuum scale [7, 9] . We further investigated the sensitivity, specificity, PPV, NPV, PLR, NLR and accuracy of different cut-off points than those suggested in the original version [9] . The cut-off points of 12 and 13 were those that best fitted the present study. Both cut-offs showed high sensitivity, specificity and almost identical accuracy. Choosing the cut-off score of 12, the sensitivity increases by 1.9% compared with a cut-off score of 13 and the specificity only decreases by 2.7%. Moreover, this is the original cut-off score proposed for the PSD in the original m-2010c validation [9] , and it perfectly fitted our population sample. Previous studies have shown an increase in accuracy with the m-2010c when the cut-off score is changed, reflecting the differences between patients with FM from different countries [10, 12, 13] . However, we found that the original cut-off score perfectly fitted our population and the m-2010c can be used in its original form.
A limitation of the current study is that we did not have an expert consensus as in Wolfe et al. [3] and therefore we chose the clinical diagnosis as the gold standard. It is possible that some clinical diagnoses were erroneous, since the clinical diagnosis is not a real gold standard. Although the 2010 ACR criteria have been scientifically translated to Spanish, there is not a Spanish adaptation and psychometric properties study of the m-2010c. The male sample size was low compared with the women's sample size; nevertheless, it is consistent with the general sex prevalence of FM. The study groups showed age differences and women and men were analysed together; however, we repeated all the analyses with age-matched and sex-separated groups, obtaining the same results showed in the present study. The main strength of the present study is its large sample size, which was from southern Spanish population with FM. We also used both the 1990c and the m-2010c in our study sample, which allowed us to compare both criteria and study the usefulness of criteria combinations.
Conclusions
The present study showed the validity of the m-2010c as a FM diagnostic tool in Spain. We suggest using the same cut-off points as the original version. However, the results suggest that using both the 1990c and the m-2010c, and meeting one of the two criteria, might be a better option than using the m-2010c alone. Future studies should examine this combination of criteria. 
